Cargando…

Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease

Accumulation and misfolding of the alpha-synuclein protein are core mechanisms in the pathogenesis of Parkinson’s disease. While the normal function of alpha-synuclein is mainly related to the control of vesicular neurotransmission, its pathogenic effects are linked to various cellular functions, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobela, Wojciech, Aebischer, Patrick, Schneider, Bernard Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693253/
https://www.ncbi.nlm.nih.gov/pubmed/26501339
http://dx.doi.org/10.3390/biom5042675
_version_ 1782407350373580800
author Bobela, Wojciech
Aebischer, Patrick
Schneider, Bernard Laurent
author_facet Bobela, Wojciech
Aebischer, Patrick
Schneider, Bernard Laurent
author_sort Bobela, Wojciech
collection PubMed
description Accumulation and misfolding of the alpha-synuclein protein are core mechanisms in the pathogenesis of Parkinson’s disease. While the normal function of alpha-synuclein is mainly related to the control of vesicular neurotransmission, its pathogenic effects are linked to various cellular functions, which include mitochondrial activity, as well as proteasome and autophagic degradation of proteins. Remarkably, these functions are also affected when the renewal of macromolecules and organelles becomes impaired during the normal aging process. As aging is considered a major risk factor for Parkinson’s disease, it is critical to explore its molecular and cellular implications in the context of the alpha-synuclein pathology. Here, we discuss similarities and differences between normal brain aging and Parkinson’s disease, with a particular emphasis on the nigral dopaminergic neurons, which appear to be selectively vulnerable to the combined effects of alpha-synuclein and aging.
format Online
Article
Text
id pubmed-4693253
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-46932532016-01-07 Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease Bobela, Wojciech Aebischer, Patrick Schneider, Bernard Laurent Biomolecules Review Accumulation and misfolding of the alpha-synuclein protein are core mechanisms in the pathogenesis of Parkinson’s disease. While the normal function of alpha-synuclein is mainly related to the control of vesicular neurotransmission, its pathogenic effects are linked to various cellular functions, which include mitochondrial activity, as well as proteasome and autophagic degradation of proteins. Remarkably, these functions are also affected when the renewal of macromolecules and organelles becomes impaired during the normal aging process. As aging is considered a major risk factor for Parkinson’s disease, it is critical to explore its molecular and cellular implications in the context of the alpha-synuclein pathology. Here, we discuss similarities and differences between normal brain aging and Parkinson’s disease, with a particular emphasis on the nigral dopaminergic neurons, which appear to be selectively vulnerable to the combined effects of alpha-synuclein and aging. MDPI 2015-10-16 /pmc/articles/PMC4693253/ /pubmed/26501339 http://dx.doi.org/10.3390/biom5042675 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Bobela, Wojciech
Aebischer, Patrick
Schneider, Bernard Laurent
Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease
title Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease
title_full Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease
title_fullStr Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease
title_full_unstemmed Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease
title_short Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease
title_sort αlpha-synuclein as a mediator in the interplay between aging and parkinson’s disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693253/
https://www.ncbi.nlm.nih.gov/pubmed/26501339
http://dx.doi.org/10.3390/biom5042675
work_keys_str_mv AT bobelawojciech alphasynucleinasamediatorintheinterplaybetweenagingandparkinsonsdisease
AT aebischerpatrick alphasynucleinasamediatorintheinterplaybetweenagingandparkinsonsdisease
AT schneiderbernardlaurent alphasynucleinasamediatorintheinterplaybetweenagingandparkinsonsdisease